Hero Image

Product Supply

This section is intended to provide information to healthcare professionals on any supply issues we are currently experiencing or any discontinuations.  Please be reassured that MSD takes supply of its products very seriously and will be doing everything it can to mitigate any supply issues.

From time to time we may experience shortages of some products and may divest or discontinue others.

MSD UK customer services
(9am-5pm, Mon-Fri)

0208 1548001

(Out of normal working hours, during public holidays and weekends, please contact our UK switchboard on 0208 1548000).


Product DescriptionSupply StatusEstimated Resupply Date
Emend 125mg oral powder sachetsOut of stockAugust 2024
Sivextro 200mg powder for concentrate for solution for infusionOut of stockSeptember 2024


Product DescriptionSupply StatusEstimated Resupply Date
GARDASIL® (National Immunisation Programme)N/APlease refer to ImmForm for NIP supply status
GARDASIL® 9Full Supply 
VAQTA® PaediatricFull Supply
VAQTA® AdultFull Supply 
HBVAXPRO® 5mcgFull Supply
HBVAXPRO® 10mcgFull Supply 
HBVAXPRO® 40mcgFull Supply 
M-M-RVAXPRO® (National Immunisation Programme)N/APlease refer to ImmForm for NIP supply status
M-M-RVAXPRO®Full Supply 
PNEUMOVAX® 23 (pre-filled syringes) National Immunisation ProgrammeN/APlease refer to ImmForm for NIP supply status
PNEUMOVAX® 23 (pre-filled syringes)Full Supply 
VAXNEUVANCE ((pneumococcal polysaccharide conjugate vaccine (15-valent, adsorbed)))Full Supply
VARIVAX®Full Supply
ZOSTAVAX® (National Immunisation Programme)N/APlease refer to ImmForm for NIP supply status
ZOSTAVAX® (Private market supply)Discontinued


MSD appoint Alloga and Alliance Healthcare as its exclusive distribution partners

From 1st February 2022, Alloga will exclusively manage the warehousing and logistics (pre wholesaler) and Alliance Healthcare Limited will be the wholesaler for MSD products across the UK, ensuring MSD vaccines and medicines get to those who need them.

The new distribution partnership with Alliance Healthcare is the result of a competitive and thorough tender process which was conducted to enable MSD to continually meets the needs of patients and those who care for them by ensuring timely distribution of products to hospitals, pharmacies, GP surgeries and clinics. The new partnership includes a strong network of dispensing points across the UK – all of which will optimise support for patients and ensure that those who need MSD’s vaccines and products can receive them.

Information about OncoTICE® (2-8 X 108 CFU Tice® BCG) powder for suspension

Due to increased global demand and as the primary supplier of OncoTICE®/(TICE® /BCG) in the UK, MSD has been experiencing supply constraints. To minimise disruption to patient care, available supply of OncoTICE®/(TICE® /BCG) is proportionally allocated across countries.

MSD are working with the Department of Health and Social Care (DHSC) and relevant professional organisations to ensure equitable distribution of the medicine across NHS.

British Association of Urological Surgeons (BAUS) guidance may be found here.

Information about MERCI Device

MSD UK no longer distributes MERCI device, effective 10th June 2024. Please contact Alliance Healthcare, customerservice@alliance-healthcare.co.uk, for more information on how to access MERCI device.


Product Description
Primaxin IV 500mg/500mg powder for infusion

Esmeron 10mg/ml solution for injection

Cancidas 50mg powder for concentrate for solution for infusion

Back to products page

This page is intended for use by UK healthcare professionals only. Trademarks appearing on this website are owned, licensed to, promoted or distributed by Merck & Co., Inc., Rahway, NJ, USA, its subsidiaries or affiliates, except as noted.

Job code: GB-NON-09684 | Date of preparation: July 2024